LadRx 10K 2017 Annual report | LADX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: accreditation, ADC, Analyze, analyzed, Andersen, antibody, anticancer, Arthur, ascending, attack, auditor, auristatin, bedside, bench, Berkeley, Bioactive, Bioconjugate, blended, book, broader, Bulletin, Caldwell, captured, carcinoma, chemist, chose, cleaved, consummate, context, conventional, Destum, digit, disseminating, Edison, Editorial, engine, essentially, exploiting, exploration, fifty, fourteen, fractional, guidancewill, Heidelberg, incremental, Joel, Kadcyla, largest, licensee, Macromolecular, maytansinoid, mediation, mediator, microenvironment, mid, MOU, nanomedicine, NantCell, neck, official, opt, ordinary, partnership, pathway, PCAOB, pegged, pled, prepayment, profound, rationally, reglect, repayment, reply, requisite, SAB, Seattle, stability, stewardship, stimulate, stood, synthesized, Takeda, toolbox, toxicology, transport, twelve, unavailability, underway, Vergell, vitro, volunteering, wound, Zyontz

Removed: abnormally, acceptance, acid, acidic, Affymax, allocate, alopecia, Annex, anticipating, anticipation, approach, Arizona, AstraZeneca, attractive, Avastin, Barbara, baseline, Benjamin, Berlin, Beta, Bevacizumab, Biopsychology, budgeting, build, buparlisib, calendar, carboplatin, Catherine, Celgene, CentRx, Cerimon, Certification, chemically, Chicago, cisplatin, cleavage, collaborative, complying, comprehensive, count, CT, Cytokine, dacarbazine, Daniel, daunorubicin, DaunoXome, DCVax, demonstrating, denial, denied, dermatological, destruction, detention, diagnosed, diagnostic, diminished, disgorgement, dispositive, distinguish, dividing, docetaxel, dosing, doubt, Doxil, DSMB, duration, Dynavax, earthquake, economist, Eisai, eligibility, Emmett, entering, epirubicin, Equilar, equivalent, eribulin, establishment, ethical, etoposide, Europe, exhibited, expand, expression, expropriation, famine, fatigue, fever, fire, flood, Galen, GBM, Genentech, Geron, GlaxoSmithKline, GmbH, guide, hair, Halaven, HIV, Hycamtin, Immunology, impending, inform, insert, inside, instability, instrumental, insurrection, interval, invasive, investigating, ipilumimab, irinotecan, Janssen, jeopardize, Johnson, Joseph, Kappa, Kelly, knowable, lawsuit, Levin, licensor, lieu, liposomal, Louisiana, Loyola, LSU, matured, medication, medstat, Michigan, minimal, modest, Monica, multiforme, nadir, nationalization, nausea, Neoplasia, Network, nivolumab, Northwest, noting, Obama, online, outlining, outweigh, overcome, overseeing, package, paclitaxel, Pankratz, payroll, pazopanib, Pennsylvania, PhD, Phi, Physiological, political, pomalidamide, preclude, prescribing, Pritzker, profile, progressing, prolonged, promoted, proportion, proximity, Psychology, Publication, reacquired, recruitment, recurrent, reformulated, regimen, region, regression, responded, revaluation, reveal, riot, Road, Rubinfeld, saline, Salkind, Sandoz, Sant, Santa, satisfy, Scott, selumetinib, shrinkage, social, spearheaded, spent, Squibb, Stem, storm, Subsidiary, sued, supply, surrendered, suspended, tech, Temodar, tenure, Thomson, timeline, tolerable, trabectedin, Tracon, transplanted, treat, treating, undergo, undesirable, uniformity, unique, unrest, unspecified, upper, utilize, veliparib, Vical, vinorelbine, vomiting, Votrient, VWAP, Webster, Wellesley, white, widely, wife, world, Yervoy

LadRx (LADX) 10-K2017 FY Annual report

Content analysis